Latest RVTY news and sentiment

Revvity (RVTY) Draws Heavy Options Interest, Is The Stock Trading At A Premium?

Revvity (RVTY) has seen a surge in options activity, with high implied volatility in its September 2026 $50 put options, indicating expectations for a significant stock movement. The stock has experienced strong recent momentum, but analysts present mixed views on its valuation, with one narrative suggesting it's 3.1% overvalued at $124.84 compared to a fair value of $121.07, while a discounted cash flow model suggests it is undervalued with a fair value of $153.02. Investors are encouraged to review the full picture and various valuation models to form their own thesis.

Revvity Director Alexis P. Michas Reports Donation of 285 Shares to Charity

Revvity, Inc. director Alexis P. Michas reported a charitable donation of 285 shares of Revvity common stock from The Cayre and Alexis Michas Foundation Corp. to a nonprofit organization. The transaction, dated August 25, 2026, was a gift at no cost. Following the donation, the foundation indirectly holds 6,985 shares, while Michas directly owns 63,780 shares and indirectly holds 500 shares through a spouse's IRA.

Revvity (NYSE: RVTY) director donates 285 shares in stock gift

Revvity (NYSE: RVTY) director Alexis P. Michas reported a bona fide gift of 285 shares of common stock from The Cayre and Alexis Michas Foundation Corp. to a charitable organization. Following this transaction, the foundation indirectly holds 6,985 shares, Michas directly holds 63,780 shares, and a spouse IRA indirectly holds 500 shares. Michas disclaims beneficial ownership of the foundation-held shares except for any pecuniary interest.

Is the Options Market Predicting a Spike in Revvity Stock?

The options market suggests a potential spike in Revvity (RVTY) stock, with the Sept. 18, 2026 $50 Put showing high implied volatility. While options traders anticipate a big move, analysts currently have a "Hold" rating on Revvity, with recent earnings estimate revisions trending downwards. This high implied volatility could indicate a trading opportunity for those looking to sell premium.

Revvity stock holds in the low-$120s as valuation stretches above analyst targets

Revvity (RVTY) stock is trading in the low-$120s, significantly above the average analyst price target of $108.36, indicating a valuation premium. Despite a 27.3% gain from its 52-week low, analysts maintain a cautious "hold" rating, suggesting potential for a pullback. The company's ability to outperform earnings expectations, even with modest revenue decline, provides a fundamental backdrop, but upcoming interim results will be crucial for justifying its current trading level.

Revvity stock trades around $123 as investors weigh latest earnings and analyst targets

Revvity Inc. stock is trading around $123.25 on the NYSE, reflecting a 27.3% gain from its 52-week low. Despite this recovery, the current price is 13.7% above the average analyst target of $108.36, indicating investor optimism. Institutional investors are increasing their exposure, aligning with the company's profile as a developer of analytical instruments for various sectors including healthcare and scientific research.

Revvity stock hits 52-week high at 122.26 USD By Investing.com

Revvity Inc.'s stock has reached a new 52-week high of $122.26, demonstrating strong market performance with significant year-to-date and six-month gains. Despite an InvestingPro analysis suggesting the stock is overvalued, the company recently exceeded Q2 earnings and revenue expectations, driven by organic growth and increased AI-related demand. However, the stock saw a premarket decline, indicating some investor apprehension.

Revvity (NYSE: RVTY) executive gifts 27,785 shares to trust

Joel S. Goldberg, an officer at Revvity (NYSE: RVTY), reported gifting 27,785 shares of common stock from his direct holdings to the Goldberg Irrevocable 2021 Trust. This transaction reduced his direct holdings to 13,729 shares, while the trust, established for his children's benefit, now indirectly holds 91,494 shares. Goldberg disclaims beneficial ownership of the trust's shares except for any pecuniary interest.

Revvity (RVTY) Earnings Numbers in Focus: EPS Exceeds Its Estimate in the Latest Reading; Closing Response: Shares Finish 1.55% Lower for the Current Session - Pretax Income Report

Revvity CEO Prahlad Singh Transfers Over 67,000 Shares to Family Trusts in Gift Transactions

Revvity CEO Prahlad R. Singh transferred over 67,000 shares of the company's common stock to two irrevocable family trusts through gift transactions dated August 13, 2026. These transfers, made at no cost, reduced Singh's direct holdings to 46,026 shares and involved disclaimers of beneficial ownership for the gifted shares. The trusts include the Singh Family Trust of 2021 for his children and the newly created Singh Marital Trust of 2026, managed by Singh and his spouse.

Revvity (NYSE: RVTY) CEO shifts stock into family trusts at $0

Revvity (NYSE: RVTY) CEO Prahlad R. Singh transferred 134,572 shares of common stock into family trusts on August 13, 2026, with the transactions reported at $0.00 per share. These bona fide gifts included 7,636 shares to an irrevocable trust for his children and 59,650 shares to the Singh Marital Trust of 2026. Following these transfers, Singh disclaims beneficial ownership of the gifted securities except for any pecuniary interest.

Revvity (NYSE:RVTY) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen has downgraded Revvity (NYSE:RVTY) from a "buy" to a "hold" rating, aligning with the broader analyst consensus of twelve hold ratings and three buy ratings, with a consensus target price of $108.36. Despite the downgrade, Revvity recently exceeded quarterly earnings expectations with an EPS of $1.41 and revenue of $729.69 million, though revenue saw a slight year-over-year decline. The company's stock opened near its 52-week high, and institutional investors hold a significant 86.65% stake.

T. Rowe Price (RVTY) reports 16.4% Revvity stake, 18.3M shares under control

T. Rowe Price Investment Management, Inc. has reported a beneficial ownership of 18,269,089 shares of Revvity Inc. common stock, which accounts for 16.4% of the outstanding class. The firm holds sole voting power over 17,089,376 shares and sole dispositive power over all 18,269,089 shares. The disclosure also notes that T. Rowe Price Capital Appreciation Fund, advised by T. Rowe Price Investment Management, holds 11,237,061 shares, representing 10.1% of the class.

T. Rowe Price Associates (RVTY) discloses 5.0% beneficial stake in Revvity

T. Rowe Price Associates has filed an amended Schedule 13G, disclosing a 5.0% beneficial ownership stake in Revvity Inc (RVTY) as of June 30, 2026. This amounts to 5,526,874 shares, with T. Rowe Price Associates holding sole voting power over 5,508,363 shares and sole dispositive power over all 5,526,874 shares. The firm explicitly denied beneficial ownership, stating the filing should not be construed as such.

Revvity (RVTY) Stock Looks Reasonable On Cash Flow Yet Rich On Earnings

Revvity (RVTY) stock has seen a 34.1% decline over the past five years. While a Discounted Cash Flow (DCF) model suggests the shares are undervalued by 23.0% at $153 per share, earnings-based multiples indicate the stock is expensive, trading at a P/E of 55.4x compared to an industry average of 37.3x. The article highlights a mixed valuation picture, with cash flow models suggesting a bargain due to anticipated growth from new products like the SuperFlex prenatal screening system, but earnings multiples pointing to overvaluation.

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity has introduced the SuperFlex prenatal screening system, a compact immunoassay instrument designed for small to mid-sized laboratories and clinics to offer preeclampsia testing and biochemical screening. This CE-IVDR certified system aims to lower financial and operational barriers to in-house prenatal screening, providing access to potentially life-saving testing for more women. The SuperFlex system is initially available in markets accepting CE-marked instruments, with expansion into the Asia-Pacific region planned for late 2026.

Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts

Revvity Inc. (NYSE:RVTY) has received an average "Hold" recommendation from analysts, with 12 out of 15 rating it a hold and three a buy. Despite exceeding quarterly earnings and revenue expectations, the company's revenue declined 1.3% year over year, and the average 12-month price target of $108.36 is below its current share price of $117.66. Institutional investors hold a significant 86.65% stake in Revvity, which also announced a quarterly dividend.